Search Results - Antoni Ribas

Refine Results
  1. 1

    Basic rules to respond to PD-1 blockade cancer immunotherapy by Antoni Ribas

    Published in Journal for ImmunoTherapy of Cancer (2025-05-01)
    Get full text
    Article


  2. 2

    Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy by Zeynep Eroglu, Antoni Ribas

    Published in Therapeutic Advances in Medical Oncology (2016-01-01)
    Get full text
    Article


  3. 3

    Neoadjuvant PD-1 blockade: a new treatment option for patients with early-stage mismatch repair deficient solid tumors by Antoni Ribas, Kristin G Anderson

    Published in Journal for ImmunoTherapy of Cancer (2025-08-01)
    Get full text
    Article


  4. 4

    Preparation of peptide–MHC and T-cell receptor dextramers by biotinylated dextran doping by Michael T. Bethune, Begoña Comin-Anduix, Yu-Hsien Hwang Fu, Antoni Ribas, David Baltimore

    Published in BioTechniques (2017-03-01)
    Get full text
    Article


  5. 5

    Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy by Arun Singh, Antoni Ribas, Theodore Scott Nowicki, Katie M Campbell, Anusha Kalbasi, Maneesha Thaker, Egmidio Medina

    Published in Journal for ImmunoTherapy of Cancer (2022-03-01)
    Get full text
    Article


  6. 6

    Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance. by Yapeng Su, Marcus Bintz, Yezi Yang, Lidia Robert, Alphonsus H C Ng, Victoria Liu, Antoni Ribas, James R Heath, Wei Wei

    Published in PLoS Computational Biology (2019-06-01)
    Get full text
    Article


  7. 7

    A topical BRAF inhibitor (LUT-014) for treatment of radiodermatitis among women with breast cancerCapsule Summary by Sanford Katz, MD, Doug Ciuba, MD, Antoni Ribas, MD, PhD, Noa Shelach, PhD, Galit Zelinger, BS, Briana Barrow, BS, Benjamin W. Corn, MD

    Published in JAAD International (2024-06-01)
    Get full text
    Article


  8. 8

    Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis by Selena Ferrian, Candace C. Liu, Erin F. McCaffrey, Rashmi Kumar, Theodore S. Nowicki, David W. Dawson, Alex Baranski, John A. Glaspy, Antoni Ribas, Sean C. Bendall, Michael Angelo

    Published in Cell Reports Medicine (2021-10-01)
    Get full text
    Article


  9. 9

    Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade by Arun Singh, Begoña Comin-Anduix, Antoni Ribas, Beata Berent-Maoz, Theodore Scott Nowicki, Luke Frankiw, Cole Peters, Mignonette Macabali, Kiana Shammaie, Crystal Quiros, Paula Kaplan-Lefko, Ignacio Baselga Carretero

    Published in Journal for ImmunoTherapy of Cancer (2023-05-01)
    Get full text
    Article


  10. 10

    Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death by Nicholas A Graham, Martik Tahmasian, Bitika Kohli, Evangelia Komisopoulou, Maggie Zhu, Igor Vivanco, Michael A Teitell, Hong Wu, Antoni Ribas, Roger S Lo, Ingo K Mellinghoff, Paul S Mischel, Thomas G Graeber

    Published in Molecular Systems Biology (2012-06-01)
    Get full text
    Article


  11. 11

    596 AMBER, Part 2B: a phase 1 study of cobolimab plus dostarlimab in patients with advanced/metastatic non-small cell lung cancer (NSCLC) previously treated with anti-PD(L)-1 thera... by Antoni Ribas, Mohammed Milhem, Diwakar Davar, Patricia LoRusso, Zeynep Eroglu, Martin Gutierrez, Arindam Dhar, Carlos Becerra, Brian Di Pace, Tianli Wang, Hailei Zhang, Srimoyee Ghosh, Shyam Srivats, Theo Borgovan, Angela Waszak

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  12. 12

    Correction: ERK mediates interferon gamma-induced melanoma cell death by Ameya Champhekar, Rachel Heymans, Justin Saco, Guillem Turon Font, Cynthia Gonzalez, Anne Gao, John Pham, June Lee, Ryan Maryoung, Egmidio Medina, Katie M. Campbell, Daniel Karin, David Austin, Robert Damioseaux, Antoni Ribas

    Published in Molecular Cancer (2024-02-01)
    Get full text
    Article


  13. 13

    ERK mediates interferon gamma-induced melanoma cell death by Ameya Champhekar, Rachel Heymans, Justin Saco, Guillem Turon Font, Cynthia Gonzalez, Anne Gao, John Pham, June Lee, Ryan Maryoung, Egmidio Medina, Katie M. Campbell, Daniel Karin, David Austin, Robert Damioseaux, Antoni Ribas

    Published in Molecular Cancer (2023-10-01)
    Get full text
    Article


  14. 14

    Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials by Antoni Ribas, Carl H June, Philip D Greenberg, Crystal L Mackall, Marcela V Maus, John E Connolly, Christopher R Cabanski, Ute Dugan, Mark D Stewart, Jeff D Allen, EnJun Yang, Alexander Marson

    Published in Journal for ImmunoTherapy of Cancer (2025-06-01)
    Get full text
    Article


  15. 15

    Human antigen-specific regulatory T cells generated by T cell receptor gene transfer. by Todd M Brusko, Richard C Koya, Shirley Zhu, Michael R Lee, Amy L Putnam, Stephanie A McClymont, Michael I Nishimura, Shuhong Han, Lung-Ji Chang, Mark A Atkinson, Antoni Ribas, Jeffrey A Bluestone

    Published in PLoS ONE (2010-07-01)
    Get full text
    Article


  16. 16

    Host immunity contributes to the anti-melanoma activity of BRAF inhibitors by Deborah A. Knight, Shin Foong Ngiow, Ming Li, Tiffany Parmenter, Stephen Mok, Ashley Cass, Nicole M. Haynes, Kathryn Kinross, Hideo Yagita, Richard C. Koya, Thomas G. Graeber, Antoni Ribas, Grant A. McArthur, Mark J. Smyth

    Published in The Journal of Clinical Investigation (2023-12-01)
    Get full text
    Article


  17. 17

    Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses by Thomas Botton, Eric Talevich, Vivek Kumar Mishra, Tongwu Zhang, A. Hunter Shain, Céline Berquet, Alexander Gagnon, Robert L. Judson, Robert Ballotti, Antoni Ribas, Meenhard Herlyn, Stéphane Rocchi, Kevin M. Brown, Nicholas K. Hayward, Iwei Yeh, Boris C. Bastian

    Published in Cell Reports (2019-10-01)
    Get full text
    Article


  18. 18

    Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity by Prabhat K. Purbey, Joowon Seo, Manash K. Paul, Keisuke S. Iwamoto, Allison E. Daly, An-Chieh Feng, Ameya S. Champhekar, Justin Langerman, Katie M. Campbell, Dörthe Schaue, William H. McBride, Steven M. Dubinett, Antoni Ribas, Stephen T. Smale, Philip O. Scumpia

    Published in Cell Reports (2024-06-01)
    Get full text
    Article


  19. 19

    Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop by Rong Li, Francois Ghiringhelli, Antoine Italiano, Antoni Ribas, Paolo Antonio Ascierto, Michael Cecchini, Joseph Paul Eder, Kurt A Schalper, Sara I Pai, Mace Rothenberg, Ellen Pure, Wolf Herve Fridman, Fatima Mechta-Grigoriou, Guy Travis Clifton, Glenn Begley, Marina Kochetkova, Paolo Provenzano

    Published in Journal for ImmunoTherapy of Cancer (2023-06-01)
    Get full text
    Article


  20. 20

    Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study by Luis de la Cruz-Merino, Lorenza Di Guardo, Jean-Jacques Grob, Alfredo Venosa, James Larkin, Grant A. McArthur, Antoni Ribas, Paolo A. Ascierto, Jeffrey T. R. Evans, Antonio Gomez-Escobar, Giulio Barteselli, Susan Eng, Jessie J. Hsu, Anne Uyei, Brigitte Dréno

    Published in Journal of Translational Medicine (2017-06-01)
    Get full text
    Article


Search Tools: